SCHEMBL77344

SCHEMBL77344

O=C1COCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29493442 0.97
SCHEMBL11551941 0.95 GAA (0.86)
SCHEMBL11557391 0.95 GAA (0.86)
SCHEMBL11562571 0.95 GAA (0.86)
SCHEMBL11554085 0.95 GAA (0.86)
SCHEMBL9542421 0.92 GAA (0.73)
Morpholine SCHEMBL29053755 0.91 GAA (0.71)
SCHEMBL11581022 0.90 GAA (0.77)
SCHEMBL18873556 0.87 GAA (0.72)
SCHEMBL440870 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3123 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4105216-B1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF GENFLEET THERAPEUTICS SHANGHAI INC (CN) 2026-05-20 EP claimed
US-20260109697-A1 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2026-04-23 US claimed
EP-4724442-A1 AGONISM-ANTAGONISM IN ENDOSOMAL TLRS BY MODULATING CHEMICAL FEATURES IN 8-OXOPURINE: PROCESS FOR PREPARATION AND APPLICATION THEREOF Council of Scientific and Industrial Research (IN) 2026-04-15 EP claimed
EP-4704830-A2 MRGPRX2 INHIBITORS AND METHODS OF USE THEREOF Septerna, Inc. (US) 2026-03-11 EP claimed
EP-4103559-B1 HETEROCYCLIC PAD4 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2026-03-04 EP claimed
US-12565496-B2 Substituted 1H-pyrrolo[3,2-b]pyridine compounds and methods of use thereof BAYER AKTIENGESELLSCHAFT (DE) 2026-03-03 US claimed
US-12486260-B2 Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer MERCK PATENT GMBH (DE) 2025-12-02 US claimed
US-12410194-B2 Potent and selective azaindole inhibitors of CDK8 and CDK19 DANA-FARBER CANCER INSTITUTE, INC. (US) 2025-09-09 US claimed
US-20250223285-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO LTD (CN) 2025-07-10 US claimed
CN-120157629-A Synthesis process of morpholone derivative 北京颖诺凯胜科技有限公司 2025-06-17 CN claimed
US-5349045-A Polymer derived from cyclic amide and medical devices manufactured therefrom UNITED STATES SURGICAL CORPORATION (US) 1994-09-20 US claimed
EP-0266950-B1 Nor-statine and nor-cyclostatine polypeptides PFIZER (US) 1993-12-29 EP claimed
US-5211662-A Bicomposite intraocular lenses ALCON LABORATORIES, INC. (US) 1993-05-18 US claimed
EP-0473337-A2 Nor-statine and nor-cyclostatine polypeptides in the treatment of ocular hypertension and glaucoma PFIZER INC. (US) 1992-03-04 EP claimed
US-5034376-A Nor-statine and nor-cyclostatine polypeptides PFIZER INC. (US) 1991-07-23 US claimed
US-4997442-A Self-supporting eye implants; hydrogel; low water content; high strength, rigidity ALCON LABORATORIES, INC. (US) 1991-03-05 US claimed
EP-0266950-A2 Nor-statine and nor-cyclostatine polypeptides PFIZER INC. (US) 1988-05-11 EP claimed
CN-87101499-A Preparation method of n-statinib and n-cyclostatini polypeptide 1988-05-11 CN claimed
EP-0258391-A1 USE OF HETEROCYCLIC NITROGEN-CONTAINING COMPOUNDS FOR REDUCING MOISTURE LOSS FROM PLANTS AND INCREASING CROP YIELD RHONE POULENC NEDERLAND B.V. (NL) 1988-03-09 EP claimed
WO-1987004321-A2 USE OF HETEROCYCLIC NITROGEN-CONTAINING COMPOUNDS FOR REDUCING MOISTURE LOSS FROM PLANTS AND INCREASING CROP YIELD RHONE-POULENC NEDERLANDS B.V. (NL) 1987-07-30 WO claimed